CIBC Asset Management
RYTM icon

CIBC Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

CIBC Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Sell
2,112
-736
-26% -$66.5K ﹤0.01% 1202
2026
Q1 		$248K Hold
2,848
– – ﹤0.01% 1094
2025
Q4 		$305K Buy
+2,848
New +$302K ﹤0.01% 964

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Asset Management's RYTM Position: Q2 2026 in Review

CIBC Asset Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 26% in Q2 2026, selling an estimated $66.5K and leaving 2,112 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1202.

CIBC Asset Management first reported a position in RYTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $305K in Q4 2025. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • CIBC Asset Management held 2,112 shares of Rhythm Pharmaceuticals worth $234K as of Q2 2026.
  • CIBC Asset Management sold 736 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $66.5K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1202 holding.
  • CIBC Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • CIBC Asset Management's Rhythm Pharmaceuticals position peaked at $305K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.